FASL Antikörper
-
- Target Alle FASL Antikörper anzeigen
- FASL (Fas Ligand (TNF Superfamily, Member 6) (FASL))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser FASL Antikörper ist unkonjugiert
-
Applikation
- Flow Cytometry (FACS), ELISA, Immunoprecipitation (IP)
- Produktmerkmale
- Purified IgG
- Aufreinigung
- Purified
- Klon
- 10F2
- Isotyp
- IgG1
- Top Product
- Discover our top product FASL Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1.0 mg/mL
-
-
Potentiation of Fas-mediated apoptosis by an engineered glycosylphosphatidylinositol-linked Fas." in: Cell death and differentiation, Vol. 9, Issue 3, pp. 329-39, (2002) (PubMed).
: "Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells." in: Carcinogenesis, Vol. 23, Issue 8, pp. 1327-33, (2002) (PubMed).
: "
-
Potentiation of Fas-mediated apoptosis by an engineered glycosylphosphatidylinositol-linked Fas." in: Cell death and differentiation, Vol. 9, Issue 3, pp. 329-39, (2002) (PubMed).
-
- Target
- FASL (Fas Ligand (TNF Superfamily, Member 6) (FASL))
- Andere Bezeichnung
- CD178 (FASL Produkte)
- Hintergrund
- Synonyms: FAS LIGAND
- Gen-ID
- 356
- UniProt
- P48023
- Pathways
- Apoptose, EGFR Signaling Pathway, Production of Molecular Mediator of Immune Response, Positive Regulation of Endopeptidase Activity
-